Rivaroxaban thromboprophylaxis for gastric/gastroesophageal junction tumors versus other tumors: A post hoc analysis of the randomized CASSINI trial.

Mones JV, Streiff MB, Khorana AA, Bendheim GA, Damaraju CV, Wildgoose P, Burton P, Riess H, Soff GA

Open source

DOI
10.1002/rth2.12549
Published
2021 Jul
Container
Research and practice in thrombosis and haemostasis
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/rth2.12549,
  title = {Rivaroxaban thromboprophylaxis for gastric/gastroesophageal junction tumors versus other tumors: A post hoc analysis of the randomized CASSINI trial.},
  author = {Mones JV and Streiff MB and Khorana AA and Bendheim GA and Damaraju CV and Wildgoose P and Burton P and Riess H and Soff GA},
  year = {2021},
  journal = {Research and practice in thrombosis and haemostasis},
  doi = {10.1002/rth2.12549},
  url = {https://doi.org/10.1002/rth2.12549}
}

RIS

TY  - JOUR
TI  - Rivaroxaban thromboprophylaxis for gastric/gastroesophageal junction tumors versus other tumors: A post hoc analysis of the randomized CASSINI trial.
AU  - Mones JV
AU  - Streiff MB
AU  - Khorana AA
AU  - Bendheim GA
AU  - Damaraju CV
AU  - Wildgoose P
AU  - Burton P
AU  - Riess H
AU  - Soff GA
PY  - 2021
JO  - Research and practice in thrombosis and haemostasis
DO  - 10.1002/rth2.12549
UR  - https://doi.org/10.1002/rth2.12549
ER  - 

APA

JV, M., MB, S., AA, K., GA, B., CV, D., P, W., P, B., H, R., & GA, S. (2021). Rivaroxaban thromboprophylaxis for gastric/gastroesophageal junction tumors versus other tumors: A post hoc analysis of the randomized CASSINI trial.. Research and practice in thrombosis and haemostasis. https://doi.org/10.1002/rth2.12549

Source records